Charles E. Schmidt College of Science Discoveries & Publications

FAU Study Demonstrates a Potentially Faster and More Accurate Mode of Cancer Treatment with New Laser Technology

Research Published in Lasers in Surgery and Medicine

BOCA RATON, Fla. (February 12, 2015) — Surgeons rely on 200-year-old technology when removing cancer--sight and touch--to determine how much to remove and what to leave alone. Laser technology pioneered at Florida Atlantic University has the promise to help a surgeon better determine if an area is cancer or healthy tissue. Moreover, when combined with laser treatment for cancer, this work lays the groundwork for laser robotic treatment of cancer. Read more.

Cone Snail Venom Holds Promise for Medical Treatments for Cancer and Addiction

Research Published in the Journal of Biological Chemistry

BOCA RATON, FL (January 9, 2015) — While considered a delicacy in some parts of the world, snails have found a more intriguing use to scientists and the medical profession offering a plethora of research possibilities. Cone snails are marine mollusks, just as conch, octopi and squid, but they capture their prey using venom. The venom of these marine critters provides leads for detection and possible treatment of some cancers and addictions. Frank Marí, Ph.D., professor in the Department of Chemistry and Biochemistry in FAU's Charles E. Schmidt College of Science at Florida Atlantic University, has focused his research on cone snail venom and has published a study in the current issue of the Journal of Biological Chemistry. Read more.

Using the Power of Computers to Harness the Human Genome May Provide Clues into the Ebola Virus

Research Published in the Journal of Bioinformatics and Proteomics

BOCA RATON, Fla. (December 16, 2014) – Ebola virus disease (EVD) is a major healthcare challenge facing the globe today and if left unchecked could become a pandemic. A limited knowledgebase exists about the Ebola virus and companies are hastening to develop vaccines and other forms to treat and cure the virus. There are no FDA approved drugs, and developing vaccines or antibodies and testing them in clinical trials is an arduous process that takes considerable time. Currently, patients infected with Ebola are only able to receive supportive care such as fluid replacement, nutritional support, pain control and blood pressure maintenance. In some cases, patients may be fortunate enough to be treated with experimental drugs. Read more.

FAU Researchers Find Novel Approach to Treating the Number One Cause of Blindness in Elderly

Study Published in Proceedings of the National Academy of Sciences

BOCA RATON, Fla. (November 10, 2014) – While oxygen is essential to our planet's life force and the way we function and stay healthy, high concentrations referred to as oxidative stress may very well be the cause of more than 70 widely-spread diseases such as cancer, heart disease, neurodegenerative diseases, and eye diseases including macular degeneration. Read more.

FAU Researchers Introduce 'The Human Dynamic Clamp' - a Groundbreaking Approach to Understanding Social Interaction

Study Published in Proceedings of the National Academy of Sciences

BOCA RATON, Fla. (August 11, 2014) – Scientists at Florida Atlantic University's Center for Complex Systems and Brain Sciences have created the Human Dynamic Clamp to address the difficult problem of studying social interactions in the laboratory. Their findings were released today in an article titled "The Human Dynamic Clamp as a Paradigm for Social Interaction" in the prestigious Proceedings of the National Academy of Sciences. Read more.